Abacavir/Lamivudine Mylan

Abacavir/Lamivudine Mylan is a combination medication used in the treatment of HIV infection. This oral medication helps manage the virus by reducing its ability to multiply in the body.

Abacavir/Lamivudine Mylan is primarily used for the treatment of HIV-1 infection in adults and children. This combination therapy is designed to lower the amount of HIV in the body, helping to improve immune function and reduce the risk of HIV-related complications. It is often prescribed as part of a broader antiretroviral treatment regimen.

Common effects of Abacavir/Lamivudine Mylan may include headaches, nausea, and fatigue. Some individuals might experience skin rashes or changes in body fat distribution. It's important to monitor for any severe reactions and consult a healthcare provider if persistent or worsening symptoms occur.

Abacavir/Lamivudine Mylan should be used with caution in individuals with a history of liver disease or kidney problems. Regular monitoring of liver function and kidney function is recommended. Patients should avoid alcohol while taking this medication, as it may increase the risk of side effects.

Abacavir/Lamivudine Mylan may interact with other medications, including certain antiretrovirals, immunosuppressants, and drugs metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this medication.